Table 2.
Results of the various variables in each group.
Variable | Week | Paricalcitol (N = 23) | P value | Placebo (N = 23) | P value |
---|---|---|---|---|---|
Hemoglobin A1c (%) | 0 | 7.4, 5.2–9.4 | 0.28 | 7.3, 5.8–10.6 | 0.36 |
12 | 7.2, 5.9–11.1 | 7.5, 5.7–10.2 | |||
F M dilation (%) | 0 | 3.4, −10.1–17.9 | 0.73 | 2.4, −30.1–21.3 | 0.85 |
12 | 3.3, −7.5–14.4 | 3.6, −3.4–17.1 | |||
N G dilation (%) | 0 | 7.8, 0.9–30.3 | 0.18 | 9.7, −1.7–33.3 | 0.36 |
12 | 4.2, 0.3–24.3 | 9.8, −2.5–30.0 | |||
Microalbumin/Cr (μg/mg) | 0 | 41.0, 1.9–1806 | 0.35 | 83.3, 1.3–7713.9 | 0.60 |
12 | 69.1, 1.7–8405 | 56.1, 1.7–8332.0 | |||
Urinary Isoprostane/Cr (ng/ml) | 0 | 2.5, 0.7–6.3 | 0.17 | 1.8, 0.3–5.0 | 0.70 |
12 | 2.0, 0.8–5.2 | 2.3, 0.4–5.5 | |||
FFA (mM) | 0 | 0.6, 0.1–1.5 | 0.03 | 0.4, 0.1–0.9 | 0.73 |
12 | 0.4, 0.1–1.4 | 0.4, 0.1–1.0 | |||
Insulin (mU/ml) | 0 | 9.9,1.6–60.2 | 0.56 | 6.1, 0.5–38.5 | 0.28 |
12 | 8.8, 0.5–53.9 | 5.4, 0.3–21.9 | |||
MCP–1 (pg/m)l | 0 | 246.8, 75.6–674.9 | 0.46 | 275.9, 120.4–781.4 | 0.93 |
12 | 268.0, 83.1–585.0 | 300.9, 120.4–637.6 | |||
TNF-α (pg/ml) | 0 | 2.5, 1.5–3.6 | 0.58 | 2.5, 1.6–4.5 | 0.13 |
12 | 2.6, 1.6–3.9 | 2.6, 1.1–4.2 | |||
IL-6 (pg/ml) | 0 | 2.8, 0.8–25.4 | 0.11 | 2.5, 1.1–26.0 | 0.27 |
12 | 2.5, 0.4–24.0 | 2.7, 1.2–25.0 | |||
ICAM-1 (ng/ml) | 0 | 242.8, 72.8–521.2 | 0.34 | 179.8, 64.9–612.8 | 0.34 |
12 | 225.4, 78.2–387.8 | 182.0, 69.2–366.9 | |||
CRP (mg/ml) | 0 | 7.4, 0.2–13.2 | 0.32 | 4.3, 0.2–13.1 | 0.02 |
12 | 5.8, 0.3–12.9 | 6.9, 0.8–13.0 |
Data are median with range.